iifl-logo

Smruthi Organics Ltd Directors Report

Add as a Preferred Source on Google
₹162
(-0.28%)
Nov 20, 2026|04:01:00 PM

Smruthi Organics Ltd Share Price directors Report

Directors Report

Dear Members,

Your Directors are pleased to present the 37th Annual Report and the Audited Financial Statements for the financial year ended 31st March, 2026.

1. Financial Highlights:

A summary of the Companys financial results for the year ended 31st March, 2026 compared to the financial results for the previous year ended 31st March, 2025, is as under:

(Figures in lakhs)

Particulars

Financial Year 2025-2026 Financial Year 2024-2025

Revenue from operations

10,196.71 12,600.79

Other Income

12.35 8.88

Total Income

10,209.06 12,609.67

Expenses

8,893.06 1 1,382.57

Profit before Depreciation, Finance Cost and Tax

1,316.00 1,227.10

Less: Finance Cost

168.45 187.00

Less: Depreciation expenses

634.87 550.10

ProfitALoss) before exceptional items and tax

512.69 490.00

Statutory impact of new Labour Codes

46.26 0.06

Profit/ (loss) before tax

466.43 -

Less: Tax expense

123.86 133.71

Net Profit/(Loss) for the period

342.57 356.29

Other Comprehensive Income (Net of Tax)

17.42 16.48

Total Comprehensive Income for the year

359.99 372.76

2. Operational Performance and State of Companys Affairs:

Revenue

Revenue from operations declined 19.08% to Rs. 10,196.71 lakhs, driven primarily by lower volumes in select domestic and export product categories. Demand softness in certain markets was a contributing factor. Additionally, in a year marked by pricing pressure, the Company consciously stepped back from price-sensitive business that would have diluted margins, choosing instead to prioritise export orders with better price realisation. This focus on value-driven pricing helped cushion the impact of volume softness and contributed directly to the improvement in margins seen during the year.

Profitability and Margin Performance

The standout story of FY26 is margin performance. Despite the 19.08% revenue decline, EBITDA grew 7.25% to Rs. 1,316 lakhs and EBITDA margin expanded sharply from 9.74% to 12.89%-a 316 basis point improvement. This was achieved through a better product mix, tighter process controls, and disciplined resource utilisation.

Finance costs fell 9.92% to Rs. 168.45 lakhs, reflecting improved working capital management. Profit Before Depreciation and Tax (PBDT) rose 10.33% to Rs. 1,147.56 lakhs. Depreciation increased 15.41% to Rs. 634.87 lakhs, reflecting infrastructure investments made in prior years to meet global regulatory standards. Profit Before Tax consequently stood at Rs. 466.43 lakhs versus Rs. 490.00 lakhs in the prior year.

PAT for the year was Rs. 342.57 lakhs versus Rs. 356.29 lakhs-a marginal decline of 3.85%, almost entirely attributable to a one-time exceptional provision of Rs. 46.26 lakhs on account of the statutory impact of the new Labour Codes. Adjusted for this item, the Company delivered improved underlying profitability.

Cost and Operational Efficiency

Raw material costs, which constitute the largest component of the Companys cost structure, declined in absolute terms in line with lower production volumes. The Company continued its efforts on alternate sourcing, vendor consolidation, and backward integration to reduce input cost dependence and improve procurement efficiency. Raw material consumption declined by 33.35% compared to the previous year.

Employee costs grew at an accelerated pace during the year, reflecting a deliberate strategic investment. The Company strengthened its quality, regulatory, and production teams in preparation for regulatory inspections and market entry in European and other regulated markets. While this has added to costs in the near term, management views this as essential to the Companys medium-term growth strategy.

The Company managed its working capital prudently without materially increasing debt, resulting in a 9.92% reduction in finance costs and a 6.63% reduction in other expenses compared to the previous year. The company was also able to reduce its long-term debt significantly ahead of schedule due to better cash accrual and working capital management.

A Landmark Regulatory Milestone: EDQM Approval

As a result of painstaking efforts taken during past few years for understanding regulatory environment and developing European and South American markets, the Company received during the year approval from the European Directorate for the Quality of Medicines & HealthCare (EDQM), one of the most rigorous regulatory standards globally. This is a significant milestone. EDQM certification qualifies the Companys APIs for supply to European Union markets and many countries worldwide that accept EDQM approvals as their benchmark covering a combined market of considerable scale and premium pricing potential. This approval validates the Companys manufacturing quality, documentation systems, and compliance infrastructure at the highest international level, and is expected to be a meaningful contributor to export revenue in the years ahead.

Similarly, Company is soon expecting regulatory inspection by ANVISA, Brazil . Management is confident in the Companys compliance readiness and views a favourable outcome of the inspection as an important milestone toward establishing a presence in one of the worlds largest pharmaceutical markets in South America.

Finished Dosage Formulations (FDF) Division

At the end of FY 2025-26, the Company took a considered management decision to discontinue its Finished Dosage Formulations (FDF) business unit. The FDF division had operated at a limited scale and, upon review, was determined to be non-core to the Companys strategic focus on Active Pharmaceutical Ingredient (API) manufacturing. Discontinuing the division allows the Company to concentrate its resources, management attention, and capital toward its core API business, regulatory expansion, and export growth. The wind-down of FDF operations will be completed during the current year.

A detailed overview has been provided under the Management Discussion and Analysis Report.

3. Dividend:

The Board has recommended a Dividend of Rs 1.50 /- per equity share (15 %) on equity share capital of 1,14,46,290 equity shares of Rs 10/- each for the year ended 31st March, 2026 .

4. Transfer to Reserves:

During the financial year, the Company has not transferred any amount to general reserve.

5. Material changes and commitments, if any, affecting the financial position of the company, having occurred since the end of the Year and till the date of the Report:

During the period between the end of the financial year and the date of this Report, the Company decided to discontinue its Finished Dosage Formulations Division, which constituted a minor segment of the Companys operations since FY 202122. The said decision has been taken with a view to focus on strengthening the Companys core business segment and is not expected to have any material adverse impact on the financial position of the Company.

Except as stated above, there have been no other material changes and commitments affecting the financial position of the Company between the end of the financial year and the date of this Report.

6. Share Capital:

The paid up Equity Share Capital as at 31st March, 2026 stood at Rs 1144.629 lakhs. During the year under review, the Company did not issue any Equity Shares. Further, the Company has not issued any convertible securities or shares with differential voting rights nor has granted any stock options or sweat equity or warrants. There has been no change in the capital structure of the Company during the year.

7. Human Resource Development (HRD) & Industrial Relations

The Company continues to focus on the development of its human resources with a view to enhancing employee performance, skills and overall organisational effectiveness.

The Company has approximately 261 employees, whose valuable contribution has played an important role in strengthening the Companys position in the industry.

The Company has adopted a "Safety First" approach across all its plants. Visible controls and fool-proof systems are being implemented to prevent accidents. Regular communication, periodic review of safety practices and continuous training programmes are conducted to maintain high safety standards.

The relationship with the workmen and staff remained cordial and harmonious during the year. The management received full cooperation from employees across all units and locations.

8. Management Discussion and Analysis

Please refer to the detailed Management Discussion and Analysis on page no 13.

9. Cautionary Statement

Statements in this Management Discussion and Analysis section of this report describing the Companys objectives, estimates and expectations may be "forward looking statements" within the meaning of the applicable laws and regulations. Actual results might differ materially from those either expressed or implied.

10. Internal Control Systems

The Company has adequate internal control procedures commensurate with the size of the company and the nature of its business with regard to purchases of inventory, fixed assets and with regard to the sale of goods.

11. Key Financial Ratios

Refer Note No 44 to the Notes to Standalone Financial Statement as on 31st March, 2026.

12. Directors Responsibility Statement

As stipulated under the provisions contained in Section 134(3) (c) read with Section 134(5) of the Companies Act, 2013 ("Act"), the Board of Directors, to the best of its knowledge and belief and according to the information and explanations obtained by it, hereby states that:

i. in the preparation of the annual accounts, the applicable accounting standards have been followed and there are no material departures;

ii. the directors have selected such accounting policies and applied them consistently and made judgments and estimates that are reasonable and prudent so as to give a true and fair view of the state of affairs of the Company at the end of the financial year and of the profit of the Company for that period;

iii. the directors have taken proper and sufficient care for the maintenance of adequate accounting records in accordance with the provisions of the Act, for safeguarding the assets of the Company and for preventing and detecting fraud and other irregularities;

iv. the directors have prepared the annual accounts of the Company on a going concern basis;

v. the directors have laid down internal financial controls to be followed by the Company and that such internal financial controls are adequate and are operating effectively; and

vi. the directors have devised proper systems to ensure compliance with the provisions of all applicable laws and that such systems are adequate and operating effectively.

13. Directors and Key Managerial Personnel

The Board of Directors of the Company is chaired by the Executive Promoter Chairman and Managing Director and has an optimum combination of Executive, Non-Executive and Independent Directors.

In accordance with the provisions of the Companies Act, 2013 and the Articles of Association of the Company, Mr. Swapnil Eaga (DIN: 01241535) retires by rotation at the ensuing Annual General Meeting and, being eligible, offers himself for re-appointment. The Members are requested to approve his re-appointment.

Based on the recommendation of the Nomination and Remuneration Committee, the Board has approved the appointment / change in designation of Ms. Smruthi Eaga (DIN: 09268342) from Non-Executive, Non-Independent Director to Whole-time Director, (Executive), liable to retire by rotation, for a period of 3 (three) years from 1st June, 2026 to 31st May, 2029, on the terms and conditions, including remuneration, as set out in the resolution, subject to approval of the Members and the Central Government.

Considering the same to be in the interest of the Company, the Members are requested to approve the said appointment / change in designation.

Ms. Smruthi Eaga has given her consent to act as Whole-time Director of the Company and has confirmed that she is not disqualified from being appointed as a Director under Section 164 of the Companies Act, 2013.

The Company has adopted a Code of Conduct for Directors and Senior Management Personnel. All Directors and Senior Management Personnel have confirmed compliance with the said Code.

None of the Directors of the Company is disqualified as on 31st March, 2026 from being appointed as a Director in terms of Section 164 of the Companies Act, 2013. As required under law, this position is also reflected in the Auditors Report.

Details with respect to the composition of the Board, meetings of the Board held during the year and attendance of the Directors thereat have been provided separately in the Annual Report, as part of the Report on Corporate Governance.

In the opinion of the Board, all Independent Directors possess the requisite qualifications, experience, expertise and integrity for the purpose of Rule 8(5)(iii-a) of the Companies (Accounts) Rules, 2014 and fulfil the criteria of independence as provided under the Companies Act, 2013. The list of key skills, expertise and core competencies of the Board is provided in the Corporate Governance Report forming part of this Annual Report.

14. Declaration by Independent Directors

All Independent Directors have submitted requisite declarations confirming that they (i) continue to meet the criteria of independence as prescribed under Section 149(6) of the Act and Regulation 16(1)(b) of the SEBI Listing Regulations and are independent; and (ii) continue to comply with the Code of Conduct laid down under Schedule IV of the Act.

15. Key Managerial Personnel

In terms of Section 203 of the Act, the Company has the following Key Managerial Personnel : Mr. Purushotham Eaga, Chairman and Managing Director, Mr. Swapnil Eaga, Jt. Managing Director and Chief Financial Officer and Ms Urvashi Khanna, Company Secretary & Compliance Officer.

16. Board Evaluation

In terms of the applicable provisions of the Act, the SEBI Listing Regulations, Nomination and Remuneration Committee and the Board of Directors have approved a framework, which lays down a structured approach, guidelines and processes to be adopted for carrying out an evaluation of the performance of all the Directors, the Board as a whole and its Committees. The evaluation process has been separately explained in this Annual Report, as a part of the Report on Corporate Governance. For the year under review, the Board carried out the evaluation of its own performance and that of its Committees and the individual Directors and the evaluation results, as collated and presented, were noted by the Board.

17. Meetings of the Board

The Board met 4 (Four) times during the financial year. The meeting details are provided in the Report on Corporate Governance that forms part of this Annual Report.

The maximum interval between any two meetings did not exceed 120 days, as prescribed in the Act and the SEBI Listing Regulations.

18. Adequacy of Internal Financial Controls related to financial statements:

The Company has in place an adequate system of internal controls, policies and procedures for ensuring orderly and efficient conduct of the business, including adherence to the Companys policies, safeguarding of its assets, prevention and detection of frauds and errors, accuracy and completeness of the accounting records and timely preparation of reliable financial disclosures.

19. Auditors:

Pursuant to the provisions of Section 139 of the Companies Act, 2013 read with Companies (Audit and Auditors) Rules, 2014, in the 33rd Annual General Meeting M/s. Gokhale & Sathe, Chartered Accountants, Mumbai (Reg. No.: 103264W) were appointed as the Statutory Auditors of the Company for a term of five years commencing from Financial year 20222023 to 2026-2027.

The Auditors Report on the Financial Statements of the Company for the year under review, is clean and there are no qualifications in the Report. Also, no frauds in terms of the provisions of Section 143(12) of the Act have been reported by the Statutory Auditors in their report for the year under review. The Notes to the Financial Statements are self explanatory and do not call for any further comments.

20. Secretarial Audit Report:

The Secretarial Audit Report submitted by the Secretarial Auditor Mr. H.R. Thakur, Practicing Company Secretary, Mumbai, in the prescribed Form MR-3 is attached as Annexure - I" and forms part of this report.

The observation made in the Secretarial Audit Report is selfexplanatory. The Report does not contain any qualification or adverse remark. Further the Company has also obtained from the Secretarial Auditor, the Annual Secretarial Compliance Report for the financial year ended 31st March, 2026, thereby confirming compliance of the applicable SEBI Regulations and circulars / guidelines issued thereunder, on behalf of the Company. The Company has complied with the applicable Secretarial Standards issued by the Institute of Company Secretaries of India.

21. Cost Audit:

Based on the recommendation of Audit Committee, the Board appointed M/s. Shrinivas Diddi and Associates, Cost Accountants, Solapur as the Cost Auditor to conduct the audit of the Companys cost records for the financial year ended 31st March, 2026. The Cost Auditor will submit his report for FY 2025-2026 by the due date.

The Cost Audit Report, for FY 2024-2025, was filed with the Central Government within the statutory timelines. The Company maintains the cost records in compliance with provisions of Section 148(1) of the Act.

Further, the Company has re-appointed M/s. Shrinivas Diddi and Associates., Cost Accountants, as the Cost Auditor for the financial year 2026-2027, to conduct an audit of its cost accounting records pertaining to the products of the Company as required by the law, at a remuneration of Rs 55,000 plus GST and reimbursement of out-of-pocket expenses.

The Company is seeking the approval of the Shareholders by means of ratification, for the remuneration to be paid to M/s. Shrinivas Diddi and Associates ., Cost Accountants, vide Item no. 4 of the Notice of 37th Annual General Meeting.

22. Conservation of Energy, Technology Absorption & Foreign Exchange:

The statement giving the particulars relating to conservation of energy, technology absorption and foreign exchange earnings and outgo, as required in terms of Section 134(3)(m) of the Act read with Rule 8(3) of the Companies (Accounts) Rules, 2014, is annexed to this Report as "Annexure II".

23. Particular regarding Employees Remuneration:

Disclosure comprising particulars with respect to the remuneration of directors and employees, as required to be disclosed in terms of the provisions of Section197(12) of the Act and Rule 5 of the Companies (Appointment and Remuneration of Managerial Personnel) Rules, 2014, is annexed to this Report as "Annexure III".

24. Particulars of Loans, Guarantees or Investments:

Company did not give any loans, guarantees and make any Investment covered under the provisions of Section 186 of the Companies Act, 2013.

25. Related Party Transactions:

Related Party Transactions entered into during the year under review were approved by the Audit Committee and the Board of Directors, from time to time and the same are disclosed in the Financial Statements of the Company for the year under review. Further, pursuant to the provisions of the Act and the SEBI Listing Regulations, the Board of Directors has, on recommendation of its Audit Committee, adopted a Policy on Related Party Transactions and the said policy is available on the website of the Company i.e. www.smruthiorganics.com.

In terms of the provisions of Section 188(1) of the Act read with the Companies (Meetings of Board and its Powers) Rules, 2014 and Regulation 23 of the SEBI Listing Regulations, all contracts/ arrangements/ transactions entered into by the Company with its related parties, during the year under review, were in the ordinary course of business of the Company and on an arms length basis.

There were no material Related Party transactions during the year.

26. Corporate Governance:

The Company is in full compliance with the requirements and disclosures that have to be made in terms of the requirements of Corporate Governance specified in SEBI Listing Regulations. Corporate Governance Report is enclosed as a part of the Annual Report along with the certificate from the Secretarial Auditor Mr. H. R. Thakur, Practicing Company Secretary confirming compliance of the code of Corporate Governance as stipulated Para E of Schedule V of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.

27. Audit Committee:

The Company has an Audit Committee in place in terms of the provisions of Regulation 18 of SEBI Listing Regulations read with Section 177 of the Companies Act, 2013.

The Composition of the Audit Committee is in compliance with the requirements as prescribed under the Act and Listing Regulations and forms part of Report on Corporate Governance. The recommendations made by the Audit Committee to the Board, from time to time during the year under review, have been accepted by the Board. The details with respect to the Audit Committee such as its terms of reference, the meetings of the Audit Committee and attendance thereat of the members of the Committee, are separately provided in this Annual Report, as a part of the Report on Corporate Governance.

28. Remuneration Policy:

The policy on remuneration and other matters provided in Section 178(3) of the Act has been disclosed in the Corporate Governance Report, which is a part of this report and is also available on website of the company www.smruthiorganics.com.

29. Risk Management Policy:

The Company is aware of the risks associated with the business. It regularly analyses and takes corrective actions for managing/ mitigating the same. The requirements of Regulation 21 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, with regard to the constitution of a Risk Management Committee are not applicable to our Company.

30. Corporate Social Responsibility (CSR):

Pursuant to Section 135(1) of the Act, the Company has constituted Corporate Social Responsibility (CSR) Committee.

The Composition of the CSR Committee is disclosed separately in the Corporate Governance report forming part of this Annual Report. The Company has in place, the CSR policy which outlines Companys philosophy towards Companys CSR program implementation. The CSR policy is available on the Companys website www.smruthiorganics.com. However, for FY 2025-2026, the Company had no CSR liability to spend therefore CSR annexure is not applicable for FY 2025-2026.

31. Prevention of Sexual Harassment of Women at Workplace:

In line with the provisions of the Sexual Harassment of Women at Workplace (Prevention, Prohibition and Redressal) Act, 2013, the Company has adopted a Policy on Prevention of Sexual Harassment at Workplace.

The Company has an Internal Complaints Committee to address the complaints of sexual harassment at workplace under the Sexual Harassment of Women at Workplace (Prevention, Prohibition and Redressal) Act, 2013. In the past and also during the financial year under review, the Company did not receive any complaint relating to sexual harassment.

32. Compliance with the provisions relating to the Maternity Benefit Act, 1961:

The Company affirms that it has duly complied with the applicable provisions of the Maternity Benefit Act, 1961, and has extended all benefits to eligible employees as prescribed under the Act.

33. Vigil Mechanism - Whistle Blower Policy :

The Company has a Whistle Blower Policy to report genuine concerns and grievances. The policy provides adequate safeguards against victimisation of persons who use the Whistle Blower mechanism. Details with respect to implementation of the Whistle Blower Policy are separately disclosed in this Annual Report, as a part of the Report on Corporate Governance. The same is also available on the website of the Company at www.smruthiorganics.com

34. Annual Return:

Pursuant to Section 92(3) read with Section 134(3)(a) of the Act, the Annual Return as on March 31, 2026 is available on the Companys website on https://smruthiorganics.com/ investor-relation/.

35. Investor Education and Protection Fund (IEPF):

The Company was not required to transfer any amount to the Investor Education and Protection Fund established by the Central Government (IEPF) during the financial year 2025-26 except the dividend declared for the financial year 2024-25 on the shares already transferred to IEPF.

36. Significant material orders passed by the Regulators / Courts/ Tribunals, if any:

Pursuant to the requirement of Section 134(3)(q) of the Companies Act, 2013 read with Rule 8(5)(vii) of the Companies (Accounts) Rules, 2014, it is confirmed that during the Financial Year under review, there are no significant material orders passed by the Regulators/ Courts/ Tribunals which would impact the going concern status of the Company and its future operations.

37. Compliance with Secretarial Standards:

The Company has complied with the applicable Secretarial Standards issued by the Institute of Company Secretaries of India.

38. Acknowledgements:

Your Directors wish to express their grateful appreciation for the co-operation and continued support received from customers, vendors, investors, shareholders, banks, regulatory authorities and the society at large during the year. We also place on record our appreciation for the contribution made by our employees at all levels and for their commitment, hard work and support in driving the growth of the Company.

For & on behalf of the Board

Purushotham Eaga

Chairman & Managing Director

DIN:00033583

Place: Solapur

Date: 13th May, 2026

Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2026, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited. All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099

ISO certification icon
We are ISO/IEC 27001:2022 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.